Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 179

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 4
Chunk 179
---

with such codes may change in the future.

In addition to uncertainties
surrounding coverage policies, there are periodic changes to reimbursement levels. Third-party payors regularly update reimbursement amounts
and also from time to time revise the methodologies used to determine reimbursement amounts. This includes routine updates to payments
to physicians, hospitals and ambulatory surgery centers for procedures during which our products are used. These updates could directly
impact the demand for our products. See “ Risk Factors - Risks Related to Government Regulation - Healthcare policy changes, including
recently enacted legislation reforming the U. S. healthcare system, could harm our business, financial condition and results of operations.”

We believe the overall escalating
cost of medical products and services being paid for by the government and private health insurance has led to, and will continue to lead
to, increased pressures on the healthcare and medical device industry to reduce the costs of products and services. Third-party payors
are developing increasingly sophisticated methods of controlling healthcare costs through prospective reimbursement and capitation programs,
group purchasing, redesign of benefits, and exploration of more cost-effective methods of delivering healthcare. In the United States,
some insured individuals enroll in managed care programs, which monitor and often require pre-approval of the services that a member will
receive. Some managed-care programs pay their providers on a per capita (patient) basis, which puts the providers at financial risk for
the services provided to their patients by paying these providers a predetermined payment per member per month and, consequently, may
limit the willingness of these providers to use our products. It is possible that third-party payor coding, coverage and reimbursement
policies will affect the need or prices for our products in the future, which could significantly affect our financial performance and
our ability to conduct our business.

In international markets,
reimbursement and healthcare payment systems vary significantly by country, and many countries have instituted price ceilings on specific
product lines and procedures. EU member states and UK impose controls on whether products are reimbursable by national or regional health
service providers and on the prices at which devices are reimbursed under state-run healthcare schemes. More and more, local, product
specific reimbursement law is applied as an overlay to medical device regulation, which has provided an additional layer of clearance
requirement.

Healthcare Reform

The United States government
has enacted a number of legislative and regulatory proposals to change the healthcare system in ways that could affect our ability to
sell our products profitably. Among policy makers and payors in the United States